Oriola Oyj (O5O.F)
Frankfurt · EUR · Healthcare · Pharmaceutical Retailers
€0.741 (+0.41%) as of
Key statistics
- Market cap
- 136.53M
- EPS (TTM)
- -0.1100
- Dividend yield
- 4.06%
- 52-week range
- 0.7280 – 1.2400
- Beta
- 0.46
- Revenue (TTM)
- 1.91B
- Profit margin
- -1.02%
- Volume
- 1.33k
About Oriola Oyj
Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, real world evidence, sales support, medical translation, pharmacovigilance and medical information, and patient support services. Further, the company provides advisory services. It serves pharmaceutical companies, pharmacies, veterinarians, hospitals, healthcare providers, special stores, retailers, and e-commerce companies. The company was founded in 1907 and is headquartered in Espoo, Finland.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Headquarters
- Espoo, Finland
- Employees
- 796
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.